FTI
PACB icon

Fiduciary Trust International’s Pacific Biosciences PACB Stock Holding History

Fiduciary Trust International’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-22,017
Closed -$114K – 111
2017
Q1 		$114K Buy
+22,017
New +$108K 0.04% 89

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Fiduciary Trust International's PACB Position: Q2 2017 in Review

Fiduciary Trust International sold out of Pacific Biosciences (PACB) in Q2 2017, closing a stake of 22,017 shares — an estimated $114K sold.

Fiduciary Trust International first reported a position in PACB in Q1 2017 and held it in 1 quarter. The position peaked at $114K in Q1 2017. 107 funds tracked by Wall St. Rank hold PACB as of Q2 2017.

  • Fiduciary Trust International reported no remaining Pacific Biosciences position as of Q2 2017 after selling out during the quarter.
  • Fiduciary Trust International sold 22,017 Pacific Biosciences shares in Q2 2017, an estimated $114K.
  • Fiduciary Trust International first reported a position in Pacific Biosciences in Q1 2017 and held it in 1 quarter.
  • Fiduciary Trust International's Pacific Biosciences position peaked at $114K in Q1 2017.
  • 107 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2017.

Based on Fiduciary Trust International's 13F filing for Q2 2017, filed 14 Aug 2017.